With the rate of cord cutting accelerating to record levels, the news for the broadcast networks is not all bad, with daytime TV increasing its growth in ad impressions during the 2022-2023 season, ...

Commercials from prescription drugs by Big Pharma copmanies have become a regular part of the American television experience.

There’s a familiar name at the top of iSpot.tv’s top 10 drug ad spending list in AbbVie’s Rinvoq, but newly approved meds from the likes of Pfizer, Bristol Myers Squibb and Eli Lilly are storming up ...

After a strong start to the year—as evidenced by the nearly 30% year-over-year increase in the top 10 brands’ first-quarter TV drug ad outlay—spending on pharmaceutical commercials has slowed ...